Raffles Medical Group (RMG)

RHB upgrades Raffles Medical to 'buy' on return to business as usual - THE EDGE SINGAPORE

Broker's Calls

RHB upgrades Raffles Medical to 'buy' on return to business as usual

RHB Group Research analyst Shekhar Jaiswal has upgraded Raffles Medical to “buy” from “neutral” with a higher target price of $1.29 from 91 cents previously.

Founders of Raffles Medical Group and Credit Bureau Asia raise respective stakes - THE EDGE SINGAPORE

Insider moves

Founders of Raffles Medical Group and Credit Bureau Asia raise respective stakes

Dr Loo Choon Yong, executive chairman of Raffles Medical Group, and Olivier Lim, the company’s non-executive and non-independent director, recently bought more shares of the compan

Raffles Medical Group posts 9.3% higher FY20 earnings of $65.9 mil thanks to new services such as PCR testing - THE EDGE SINGAPORE

Results

Raffles Medical Group posts 9.3% higher FY20 earnings of $65.9 mil thanks to new services such as PCR testing

Raffles Medical Group (RMG) has reported earnings of $65.9 million for the FY2020 ended December, 9.3% higher than earnings of $60.3 million a year ago.

Healthcare

Raffles Medical might have gone regional but Covid war brings it back to the homefront

Dr Loo Choon Yong, executive chairman of Raffles Medical Group, says he has never experienced a crisis like the Covid-19 pandemic in his half a century as a healthcare professional.

Broker's Calls

PhillipCapital remains neutral on Raffles Medical, says current downturn 'does not represent' business environment

PhillipCapital is maintaining its “neutral” call on Raffles Medical with a revised target price of 94 cents.

Investing ideas

Analysts remain cautious on Raffles Medical as it remains infectious from Covid-19

Analysts are maintaining a cautious stance on Raffles Medical Group following the announcement of its 1H2020 results on July 27.

Results

Raffles Medical posts 38.2% drop in 1H2020 earnings, but expects to "remain profitable" this year

Earnings of healthcare provider Raffles Medical Group plunged 38.2% to $17.2 million for 1H2020 ended June, from $27.9 million a year ago, following the deferment of elective surgeries and a dip in

Broker's Calls

Raffles Medical kept at 'neutral' as Singapore operations flatline

SINGAPORE (Apr 28): RHB Group Research is maintaining its “neutral” recommendation on Raffles Medical Group (RMG) with a slightly lowered target price of 93 cents from 96 cents previously.

Results

Raffles Medical posts 45.5% lower 1Q earnings of $7.5 mil on Covid-19 impact in China, Hong Kong

SINGAPORE (Apr 27): Raffles Medical Group (RMG) has announced earnings of $7.5 million for 1Q2020 ended March,

Broker's Calls

Analysts remain neutral on Raffles Medical as it copes with the flu bug

SINGAPORE (Feb 25): Analysts remain cautious in their calls for Raffles Medical, following the release of its FY2019 results on Feb 24.

×